{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+gel&page=7", "query": { "intervention": "Control gel", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 637, "total_pages": 64, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+gel&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+gel&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T15:36:43.734Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01183169", "title": "Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "Alisporivir", "type": "DRUG" }, { "name": "Peginterferon alfa-2a", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 459, "start_date": "2010-08", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2016-08-25", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 18, "location_summary": "San Diego, California • Ventura, California • Bradenton, Florida + 13 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01183169" }, { "nct_id": "NCT07030725", "title": "Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Regulation of Energy Expenditure" ], "interventions": [ { "name": "Menthol Gel", "type": "DRUG" }, { "name": "Sham", "type": "DRUG" }, { "name": "Time control", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 12, "start_date": "2025-03-27", "completion_date": "2025-06-09", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07030725" }, { "nct_id": "NCT00689117", "title": "A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris", "Acne" ], "interventions": [ { "name": "CT Gel", "type": "DRUG" }, { "name": "Clindamycin Gel (clindamycin )", "type": "DRUG" }, { "name": "Tretinoin Gel (tretinoin)", "type": "DRUG" }, { "name": "Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1649, "start_date": "2008-04", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Hot Springs, Arkansas + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00689117" }, { "nct_id": "NCT00792688", "title": "Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Wounds" ], "interventions": [ { "name": "GLYC-101 Gel (0.1%)", "type": "DRUG" }, { "name": "GLYC-101 Gel (1.0%)", "type": "DRUG" }, { "name": "GLYC-101 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TR Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "25 Years to 70 Years" }, "enrollment_count": 26, "start_date": "2008-10", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 1, "location_summary": "Beverly Hills, California", "locations": [ { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00792688" }, { "nct_id": "NCT06378086", "title": "RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Aging" ], "interventions": [ { "name": "RHA® Redensity with new anesthetic agent", "type": "DEVICE" }, { "name": "RHA® Redensity with lidocaine", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Teoxane SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 20, "start_date": "2024-06-11", "completion_date": "2025-09", "has_results": false, "last_update_posted_date": "2025-04-11", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 2, "location_summary": "Birmingham, Alabama • New York, New York", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06378086" }, { "nct_id": "NCT02949960", "title": "DMT210 Topical Gel in the Treatment of Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "DMT210 Topical Gel", "type": "DRUG" }, { "name": "Vehicle Control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dermata Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 19, "start_date": "2016-10", "completion_date": "2017-07-14", "has_results": false, "last_update_posted_date": "2018-04-18", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 2, "location_summary": "Houston, Texas • Norfolk, Virginia", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02949960" }, { "nct_id": "NCT03566979", "title": "Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post-operative Dental Pain" ], "interventions": [ { "name": "Test naproxen sodium tablet", "type": "DRUG" }, { "name": "Commercial naproxen sodium tablet", "type": "DRUG" }, { "name": "Commercial naproxen sodium liquid gels capsule", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "17 Years to 50 Years" }, "enrollment_count": 501, "start_date": "2018-08-13", "completion_date": "2019-04-15", "has_results": true, "last_update_posted_date": "2020-04-09", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03566979" }, { "nct_id": "NCT01254162", "title": "Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oily Skin", "Seborrhea" ], "interventions": [ { "name": "MTC896 Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mimetica Pty Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 135, "start_date": "2010-07", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2014-09-12", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 1, "location_summary": "Paramus, New Jersey", "locations": [ { "city": "Paramus", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01254162" }, { "nct_id": "NCT03170388", "title": "A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "IDP-126 Gel", "type": "DRUG" }, { "name": "IDP-126 Component A", "type": "DRUG" }, { "name": "IDP-126 Component B", "type": "DRUG" }, { "name": "IDP-126 Component C", "type": "DRUG" }, { "name": "IDP-126 Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "9 Years to 99 Years" }, "enrollment_count": 741, "start_date": "2017-10-05", "completion_date": "2019-04-23", "has_results": true, "last_update_posted_date": "2021-11-10", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 29, "location_summary": "Hot Springs, Arkansas • Fremont, California • Sacramento, California + 24 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boynton Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03170388" }, { "nct_id": "NCT00713609", "title": "Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Benzoyl peroxide gel", "type": "DRUG" }, { "name": "Clindamycin gel", "type": "DRUG" }, { "name": "Tazarotene cream", "type": "DRUG" }, { "name": "Vehicle gel", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 591, "start_date": "2008-06", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2017-03-06", "last_synced_at": "2026-10-22T15:36:43.734Z", "location_count": 16, "location_summary": "Little Rock, Arkansas • Fremont, California • Sacramento, California + 13 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00713609" } ] }